Westonci.ca is the premier destination for reliable answers to your questions, brought to you by a community of experts. Experience the ease of finding quick and accurate answers to your questions from professionals on our platform. Join our Q&A platform to connect with experts dedicated to providing accurate answers to your questions in various fields.

An introduction of recombinant DNA technology to pharmaceutical industry did NOT allow for:
a. Improved drug safety
b. High level of drug modification/alteration
c. Mass-production of the biopharmaceuticals
d. Higher average prices of the major biopharmaceuticals
e. All of the above were the consequences of the switch to recombinant DNA technology in pharmaceutical industry